BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32814419)

  • 1. Metabolically Healthy and Unhealthy Normal Weight and Obesity.
    Stefan N
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):487-493. PubMed ID: 32814419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity.
    Dobson R; Burgess MI; Sprung VS; Irwin A; Hamer M; Jones J; Daousi C; Adams V; Kemp GJ; Shojaee-Moradie F; Umpleby M; Cuthbertson DJ
    Int J Obes (Lond); 2016 Jan; 40(1):153-61. PubMed ID: 26271188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiometabolic risk management in type 2 diabetes and obesity.
    Taylor AM
    Curr Diab Rep; 2008 Oct; 8(5):345-52. PubMed ID: 18778582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women.
    Peppa M; Koliaki C; Papaefstathiou A; Garoflos E; Katsilambros N; Raptis SA; Hadjidakis DI; Dimitriadis GD
    Obesity (Silver Spring); 2013 Sep; 21(9):1807-14. PubMed ID: 23696298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review.
    Roberson LL; Aneni EC; Maziak W; Agatston A; Feldman T; Rouseff M; Tran T; Blaha MJ; Santos RD; Sposito A; Al-Mallah MH; Blankstein R; Budoff MJ; Nasir K
    BMC Public Health; 2014 Jan; 14():14. PubMed ID: 24400816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and Lifestyle Traits of Metabolic Dysfunction in the Absence of Obesity.
    Klitgaard HB; Kilbak JH; Nozawa EA; Seidel AV; Magkos F
    Curr Diab Rep; 2020 Mar; 20(6):17. PubMed ID: 32232577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and pathophysiology of the cardiometabolic syndrome.
    Kirk EP; Klein S
    J Clin Hypertens (Greenwich); 2009 Dec; 11(12):761-5. PubMed ID: 20021538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population.
    Shaharyar S; Roberson LL; Jamal O; Younus A; Blaha MJ; Ali SS; Zide K; Agatston AA; Blumenthal RS; Conceição RD; Santos RD; Nasir K
    J Obes; 2015; 2015():178526. PubMed ID: 25838943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic health in normal-weight and obese individuals.
    Schulze MB
    Diabetologia; 2019 Apr; 62(4):558-566. PubMed ID: 30569272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The metabolic syndrome and inflammation: actual issues of pathogenesis].
    Sveklina TS; Talantseva MS; Barsukov AV
    Klin Lab Diagn; 2013 Mar; (3):7-10. PubMed ID: 23808015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
    Robinson LE; Graham TE
    Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolically healthy and unhealthy obese--the 2013 Stock Conference report.
    Samocha-Bonet D; Dixit VD; Kahn CR; Leibel RL; Lin X; Nieuwdorp M; Pietiläinen KH; Rabasa-Lhoret R; Roden M; Scherer PE; Klein S; Ravussin E
    Obes Rev; 2014 Sep; 15(9):697-708. PubMed ID: 25059108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.
    Goran MI; Alderete TL
    Nestle Nutr Inst Workshop Ser; 2012; 73():49-60; discussion p61-6. PubMed ID: 23128765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Body Compositional Factors Associated with Metabolic Syndrome in Obese Koreans: A Cross-Sectional Study.
    Kim YM; Kim S; Kim SH; Won YJ
    Metab Syndr Relat Disord; 2018 Aug; 16(6):290-298. PubMed ID: 29717940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity.
    Bush EN
    Endocrine; 2006 Feb; 29(1):1-3. PubMed ID: 16622286
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on the cardiometabolic syndrome.
    Sowers JR
    Clin Cornerstone; 2001; 4(2):17-23. PubMed ID: 11838324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiometabolic syndrome and sarcopenic obesity in older persons.
    Dominguez LJ; Barbagallo M
    J Cardiometab Syndr; 2007; 2(3):183-9. PubMed ID: 17786082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a paradox in obesity?
    Goyal A; Nimmakayala KR; Zonszein J
    Cardiol Rev; 2014; 22(4):163-70. PubMed ID: 24896249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.